NCT06175845View on ClinicalTrials.gov

Endoscopic Radiofrequency Ablation for Unresectable Cholangiocarcinoma

NANot yet recruitingINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

February 29, 2024

Primary Completion Date

January 31, 2026

Study Completion Date

July 31, 2026

Conditions
CholangiocarcinomaKlatskin TumorBile Duct CancerLiver Cancer
Interventions
PROCEDURE

Intraductal biliary radiofrequency ablation

Radiofrequency ablation via catheter and transpapillary access of malignant bile duct obstruction

Trial Locations (1)

Unknown

University Medical Center Hamburg-Eppendorf, Hamburg

All Listed Sponsors
lead

Universitätsklinikum Hamburg-Eppendorf

OTHER

NCT06175845 - Endoscopic Radiofrequency Ablation for Unresectable Cholangiocarcinoma | Biotech Hunter | Biotech Hunter